Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI)

[1]  M. Buchbinder,et al.  Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Results from the LRT Trial. , 2019, American heart journal.

[2]  B. Prendergast,et al.  Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. , 2019, European heart journal.

[3]  L. W. Andersen,et al.  Five-Year Clinical and Echocardiographic Outcomes From the NOTION Randomized Clinical Trial in Patients at Lower Surgical Risk , 2019, Circulation.

[4]  C. Otto.  Informed Shared Decisions for Patients with Aortic Stenosis. , 2019, The New England journal of medicine.

[5]  M. Buchbinder,et al.  TAVR in Low-Risk Patients: 1-Year Results From the LRT Trial. , 2019, JACC. Cardiovascular interventions.

[6]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[7]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[8]  S. Anderson,et al.  Long-Term Durability of Transcatheter Aortic Valve Prostheses. , 2019, Journal of the American College of Cardiology.

[9]  P. Lancellotti,et al.  The Long Quest for the Holy Grail in Transcatheter Aortic Bioprosthesis: Durability and Long-Term Performance. , 2019, Journal of the American College of Cardiology.

[10]  D. Capodanno,et al.  Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk. , 2019, Journal of the American College of Cardiology.

[11]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[12]  L. W. Andersen,et al.  Five-Year Clinical and Echocardiographic Outcomes from the Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial in Lower Surgical Risk Patients. , 2019, Circulation.

[13]  T. Bilfinger,et al.  Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis. , 2018, Journal of the American College of Cardiology.

[14]  A. Cribier,et al.  Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[15]  V. Falk,et al.  Kommentar zu den Leitlinien (2017) der ESC/EACTS zum Management von Herzklappenerkrankungen , 2018, Der Kardiologe.

[16]  C. Hamm,et al.  Outcome after transvascular transcatheter aortic valve implantation in 2016 , 2017, European heart journal.

[17]  Alan S. Brown,et al.  ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, Americ , 2017, Journal of the American College of Cardiology.

[18]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[19]  B. Prendergast,et al.  Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ , 2017, European heart journal.

[20]  I. Palacios,et al.  Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. , 2017, Journal of the American College of Cardiology.

[21]  Jeroen J. Bax,et al.  Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint. , 2017, European heart journal.

[22]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[23]  D. Adams,et al.  1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses. , 2017, JACC. Cardiovascular interventions.

[24]  J. Leipsic,et al.  Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. , 2017, Journal of the American College of Cardiology.

[25]  B. Carabello.  Valve-in-Valve TAVR: Insights Into the Pathophysiology of Aortic Stenosis. , 2017, Journal of the American College of Cardiology.

[26]  A. M. Kasel,et al.  TAVI in Bicuspid Aortic Valves 'Made Easy'. , 2017, European heart journal.

[27]  Craig D. Miller,et al.  Transatlantic editorial on transcatheter aortic valve replacement. , 2017, The Journal of thoracic and cardiovascular surgery.

[28]  Andrew S. Mugglin,et al.  Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.

[29]  John D Carroll,et al.  2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. , 2017, Journal of the American College of Cardiology.

[30]  S. Kaul,et al.  2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2017, Journal of the American College of Cardiology.

[31]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Circulation.

[32]  Dimitris Mavridis,et al.  Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. , 2016, European heart journal.

[33]  C. Hamm,et al.  Qualitätskriterien zur Durchführung der kathetergestützten Aortenklappenimplantation (TAVI) , 2016, Der Kardiologe.

[34]  B. Iung,et al.  TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. , 2016, European heart journal.

[35]  J. Coselli,et al.  3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. , 2016, Journal of the American College of Cardiology.

[36]  J. Leipsic,et al.  Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis , 2016, The Lancet.

[37]  J. Leipsic,et al.  Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter Study. , 2016, JACC. Cardiovascular interventions.

[38]  R. Guyton,et al.  Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis: Early Success But Concerning Red Flags. , 2016, JACC. Cardiovascular interventions.

[39]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[40]  M. Leon,et al.  Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure. , 2016, Journal of the American College of Cardiology.

[41]  A. Colombo,et al.  5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis. , 2015, JACC. Cardiovascular interventions.

[42]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[43]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[44]  R. Lange,et al.  Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. , 2015, Journal of the American College of Cardiology.

[45]  P. Wenaweser,et al.  Transcatheter aortic valve replacement in bicuspid aortic valve disease. , 2014, Journal of the American College of Cardiology.

[46]  A. Colombo,et al.  Bicuspid aortic valve: any room for TAVR? , 2014, Journal of the American College of Cardiology.

[47]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[48]  Marjan van den Akker,et al.  Multimorbidity patterns: a systematic review. , 2014, Journal of clinical epidemiology.

[49]  R. Lange,et al.  The German Aortic Valve Registry (GARY): in-hospital outcome , 2013, European heart journal.

[50]  Andreas Beckmann,et al.  German Aortic Valve Score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[51]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[52]  Scott Lim,et al.  Two-year outcomes after transcatheter or surgical aortic-valve replacement. , 2012, The New England journal of medicine.

[53]  B. Prendergast,et al.  ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. , 2012, European heart journal.

[54]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[55]  G. Filippatos,et al.  [Guidelines on the management of valvular heart disease]. , 2013, Revista espanola de cardiologia.